5-Hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: Importance of the 5-HT(1B) receptor

British Journal of Pharmacology

Volumn 128, Issue 3, 1999, Pages 730-734

  Morecroft, Ian ^a   Heeley, Robert P ^a   Prentice, Howard M ^a   Kirk, Alan ^b   MacLean, Margaret R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

5 HT(2A) 5 HT(1D) and 5 HT(1B) receptors; Contraction; Human pulmonary arteries

Indexed keywords

2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; 3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; 5 CARBAMOYLTRYPTAMINE; KETANSERIN; SEROTONIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 2A ANTAGONIST; SUMATRIPTAN;

ARTICLE; HUMAN; HUMAN TISSUE; ISOLATED ARTERY; LUNG VASOCONSTRICTION; PRIORITY JOURNAL; PULMONARY ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BENZAMIDES; BIPHENYL COMPOUNDS; DNA PRIMERS; HUMANS; KETANSERIN; MUSCLE CONTRACTION; PIPERAZINES; PIPERIDONES; PULMONARY ARTERY; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN ANTAGONISTS; SPIRO COMPOUNDS;

EID: 0032751507     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702841     Document Type: Article

References (28)

1. ANDERSON, G.M., STEVENSON, J.M, & COHEN, D.J. (1987). Steady-State model for plasma free and platelet serotonin in man. Life Sci., 41, 1777-1785.
2. BRADLEY, P.B., ENGEL, G., FENIUK, W., FOZARD, J.R., HUMPHREY, P.P.A., MIDDLEMISS, D.N., RICHARDSON, B.P. & SAXENA, P.R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacol., 25, 563-576.
3. BRENNER, O. (1935). Pathology of vessels of the pulmonary circulation. Arch. Int. Med., 56, 211-237.
4. BREUER, J., GEORGARAKI, A., SIEVERDING, L., BADEN W. & APITZ, J. (1996). Increased turnover of serotonin in children with pulmonary hypertension secondary to congenital heart disease. Pediatric. Cardiol., 17, 214-219.
5. BRINK, C., CERRINA, C., LABAT, C., VERLEY, J. & BENVENISTE, J. (1988). The effect of contractile agonists on isolated pulmonary arterial and venous muscle preparations derived from patients with primary pulmonary hypertension. Am. Rev. Resp. Dis., 137, A106.
6. 1-like receptors revealed by precontraction of rabbit isolated mesenteric artery. Br. J. Pharmacol., 114, 309-314.
7. 1D receptor subtypes mediating cerebral vaso-constriction. Cephalagia, 15, 99.
8. CORTIJO, J., MARTI-CABRERA, M., BERNABEU, E., DOMENECH, T., BOU, J., FERNANDEZ, A.G., BELETA, J., PALACIOS, J.M. & MORCILLO, E.J. (1997). Characterisation of 5-H receptors on human pulmonary artery and vein: functional and binding studies. Br. J. Pharmacol., 122, 1455-1463.
9. DOMENIGHETTI, G, LEUENBERGER, P & FEIHL, F. (1997). Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension. Monaldi Arch. Chest Dis., 52, 429-433.
10. FRID, M.G., DEMPSEY, E.C., DURMOWICZ, A.G., & STENMARK, K.R. (1997). Smooth muscle cell heterogeneity in pulmonary and systemic vessels. Importance in vascular disease. Arterioscler. Thromb. Vasc. Biol., 17, 1203-1209.
11. GOULD, V.E., LINNOILA, R.I., MEMOLI, V.A. & WARREN, W.H. (1983). Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest., 49, 519-537.
12. 1D subtype. Br. J. Pharmacol., 106, 703-709.
13. HERVÉ, P., DROUET, L., DOSQUET, C., LAUNAY, J-M., RAIN, B., SIMONNEAU, G., CAEN, J. & DUROUX, P. (1990). Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am. J. Med., 89, 117-120.
14. HERVÉ, P., LAUNAY, J.M., SCROBOHACI, M.L., BRENOT, F., SIMONNEAU, G., PETITPRETZ, P., POUBEAU, P. & CERRINA, J. (1995). Increased plasma serotonin in primary pulmonary hypertension. Am. J. Med., 99, 249-254.
15. JOHNSON, D.E. & GEORGIEFF, M.K. (1989). Pulmonary neuroendocrine cells. Their secretory products and their potential role in health and chronic lung disease. Am. Rev. Respir. Dis., 140, 1807-1812.
16. 1D beta receptors. Circulation. 90, 1141-1153.
17. 1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: influence of vascular endothelium and tone. Pulm. Pharmacol., 7, 65-72.
18. 1-like receptor mediated vasoconstriction in human pulmonary artery. Br. J. Pharmacol., 119, 277-282.
19. MACLEAN, M.R., McCULLOCH, K.M. & BAIRD, M. (1994b). Endothelin ETA-and ETB-mediated vasoconstriction in rat pulmonary arteries and arterioles. J. Cardiovasc. Pharmacol., 23, 838-845.
20. MACLEAN, M.R., SMITH, G.C. & TEMPLETON, A.G.B. (1993). Adverse reactions to sumatriptan. Letter to Lancet, 341, 1092, 1164.
21. MACLEAN, M.R., SWEENEY, G., BAIRD, M., MCCULLOCH, K.M., HOUSLAY M & MORECROFT, I. (1996b). 5-hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br. J. Pharmacol., 119, 917-930.
22. McCULLOCH, K.M., DOCHERTY, C.C., MORECROFT, I, & MACLEAN, M.R. (1996). Endothelin-B receptor-mediated contraction in human pulmonary resistance arteries. Br. J. Pharmacol., 119, 1125-1130.
23. 1D receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 312-360.
24. 1B receptor selectivity for 5-HT terminal autoreceptor activity; an in vivo microdialysis study in the freely-moving guinea pig. Neuropharmacology, 36, 549-557.
25. SINGHAL, S., HENDERSON, R., HORSFIELD, K., CUMMING, G. (1973). Morphometry of the human pulmonary arterial tree-Circ. Res., 33, 190-197.
26. SWEENEY, G., TEMPLETON, A., CLAYTON, R.A., BAIRD, M., SHERIDAN, S., JOHNSTON, E.D. & MACLEAN, M.R. (1995). Contractile responses to sumatriptan in isolated bovine pulmonary artery rings: relationship to tone and cyclic nucleotide levels. J. Cardiovasc. Pharmacol., 26, 751-760.
27. ULLMER, C., SCHMUCK, K., KALKMAN, H.O & LUBBERT, H. (1995). Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett., 370, 215-221.
28. 1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA. Br. J. Pharmacol., 124, 1345-1354.